Page last updated: 2024-11-04

phenyl-n-tert-butylnitrone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

phenyl-N-tert-butylnitrone: a spin-trapping agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID638877
CHEMBL ID13210
MeSH IDM0093330

Synonyms (45)

Synonym
n-tert-butyl-.alpha.-phenylnitrone
2-propanamine, 2-methyl-n-(phenylmethylene)-, n-oxide
3376-24-7
n-t-butyl-alpha-phenylnitrone
phenyl-n-tert-butylnitrone
(z)-benzylidene(tert-butyl)azane oxide
inchi=1/c11h15no/c1-11(2,3)12(13)9-10-7-5-4-6-8-10/h4-9h,1-3h3/b12-9
azane, (1,1-dimethylethyl)(phenylmethylene)-, oxide, (z)-
n-tert-butyl-alpha-phenylnitrone ,
n-benzylidene-tert-butylamine n-oxide
B1701 ,
phenyl tert-butyl nitrone
CHEMBL13210
n-tert-butyl-a-phenylnitrone
n-tert-butyl-1-phenylmethanimine oxide
n-tert-butyl-|a-phenylnitrone
phenyl n-t-butylnitrone
(z)-n-benzylidene-2-methylpropan-2-amine oxide
AKOS015888338
AKOS025310189
benzylidene-tert-butylamine oxide
phenyl t-butylnitrone [inci]
2-methyl-n-(phenylmethylene)-2-propanamine n-oxide
52392-70-8
pbn [mi]
phenyl t-butylnitrone
(z)-n-(tert-butyl)-1-phenylmethanimine oxide
2-propanamine, 2-methyl-n-(phenylmethylene)-, n-oxide, (n(z))-
3I91332OPG ,
n-tert-butyl phenyl nitrone
n-tert-butyl-alpha-phenylnitrone [pbn]
119391-92-3
mfcd00008799
GS-3623
unii-3i91332opg
J-019319
n-benzylidene-2-methylpropan-2-amine oxide
F0001-0991
(z)-n-tert-butyl-1-phenylmethanimine oxide
HY-128463
CS-0099161
n-tert-butyl-d9-phenyl-d5-nitrone
A919030
(z)-n-tert-butyl-1-phenylmethanimineoxide
n-ert-utyl-lpha-henylnitrone

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Several analogs of 2 were prepared in attempts to improve on its weak antioxidant activity while retaining the desirable side effect profile."( Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
Bernardelli, P; Bowen, SM; Chaney, SF; Fevig, TL; Friedrich, D; Janowick, DA; Jones, BK; Keeley, FJ; Kehne, JH; Ketteler, B; Ohlweiler, DF; Paquette, LA; Robke, DJ; Thomas, CE, 1996
)
0.29
" These results document the ability of rat P450 2E1 to metabolize NDMA to toxic reactive intermediates and demonstrate that this cell line provides a useful model for studying the mechanisms of metabolism-mediated toxicity and carcinogenesis."( Heterologous expression of rat P450 2E1 in a mammalian cell line: in situ metabolism and cytotoxicity of N-nitrosodimethylamine.
Hollenberg, PF; Lin, HL; Roberts, ES, 1998
)
0.3
" The present study was conducted to characterise the toxic effect of L-CPA in primary cell cultures of rat cerebellar granule cells in vitro."( Neurotoxic effect of L-2-chloropropionic acid on primary cultures of rat cerebellar granule cells.
Fonnum, F; Lock, EA; Rustad, A; Sturgess, NC, 2000
)
0.31
"Amiodarone (AM), an antidysrrhythmic drug, can produce serious adverse effects, including potentially fatal AM-induced pulmonary toxicity (AIPT)."( Aryl radical involvement in amiodarone-induced pulmonary toxicity: investigation of protection by spin-trapping nitrones.
Bedard, LL; Brien, JF; Comeau, JL; Hill, BC; Massey, TE; Nicolescu, AC; Racz, WJ; Takahashi, T, 2007
)
0.34

Pharmacokinetics

ExcerptReferenceRelevance
" The time course of PBN concentrations in all tissues followed similar curves, and declined rather steeply after the 30-min maximum with a biological half-life of 134 min."( HPLC procedure for the pharmacokinetic study of the spin-trapping agent, alpha-phenyl-N-tert-butyl nitrone (PBN).
Chen, G; Griffin, M; McCay, PB; Poyer, JL, 1990
)
0.28

Compound-Compound Interactions

ExcerptReferenceRelevance
" The potential use of OKN-007 in combination with neurotropic compounds such as the lanthionine ketamine esters is discussed for glioblastoma multiforme as well as for various other indications leading to dementia, such as aging, septic shock, and malaria infections."( Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.
Castro Faria Neto, HC; Floyd, RA; Hensley, K; Towner, RA; Zimmerman, GA, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
" The mean oral bioavailability of PBN was 85."( Pharmacokinetics and metabolism of the reactive oxygen scavenger alpha-phenyl-N-tert-butylnitrone in the male Sprague-Dawley rat.
Kalgutkar, AS; LaFontaine, M; Trudeau-Lame, ME, 2003
)
0.32
" The findings demonstrated herein therefore strongly suggest that the amphiphilic character enhances the bioavailability of the antioxidants and allows for a selective targeting of mitochondria."( Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
Böker, J; Durand, G; Hardeland, R; Ortial, S; Pappolla, MA; Poeggeler, B; Polidori, A; Pucci, B, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" Thus open-chest dogs undergoing a 15-min coronary occlusion and 4 h of reperfusion were given one of the following intracoronary infusions: desferrioxamine (DF) beginning 2 min before reperfusion (group I), DF beginning 1 min after reperfusion (group II), iron-loaded DF in dosage identical to group I (group III), or vehicle (controls, group IV)."( Iron-mediated radical reactions upon reperfusion contribute to myocardial "stunning".
Bolli, R; Jeroudi, MO; Lai, EK; Li, XY; McCay, PB; Patel, BS; Triana, JF, 1990
)
0.28
" First, a dose-response curve for the effects of PBN on force frequency (n = 8) was established by comparing PBN-treated muscle strips (0."( N-tert-butyl-alpha-phenylnitrone: a free radical trap with unanticipated effects on diaphragm function.
Andersen, KA; Clanton, TL; Diaz, PT; Wright, VP, 1996
)
0.29
" Exposure of the GM2E1 cells to NDMA for 4 days caused severe decreases in cell viability, as determined by crystal violet uptake, and showed a sigmoidal dose-response curve with a median lethal dose of 17 microM."( Heterologous expression of rat P450 2E1 in a mammalian cell line: in situ metabolism and cytotoxicity of N-nitrosodimethylamine.
Hollenberg, PF; Lin, HL; Roberts, ES, 1998
)
0.3
" High dosage nicotine treatment significantly increased the MPTP-induced loss of body weight and resulted in a significantly decreased striatal dopamine content and an increased dopamine turnover in comparison with the MPTP-treated controls at day 15."( Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo.
Earl, CD; Ferger, B; Kuschinsky, K; Oertel, WH; Spratt, C; Teismann, P, 1998
)
0.3
" Dose-response curves were made for each of the additives (n> or =4 for each dose)."( Improving the preservation of isolated rat skeletal muscles stored for 16 hours at 4 degrees C.
Bär, DP; de Smet, M; de With, MC; Kon, M; Kroese, AB; van der Heijden, EP; Werker, PM, 2000
)
0.31
" The potential clinical utility of PBN will have to be assessed using a post-injury dosing regime."( alpha-Phenyl-tert-N-butyl nitrone (PBN) improves functional and morphological outcome after cortical contusion injury in the rat.
Clausen, F; Hillered, L; Hovda, DA; Lewén, A; Marklund, N; Olsson, Y, 2001
)
0.31
" PBN administration for 14 days with a daily dosage of 30 mg/kg provided substantial protection against killing and oxidative damage to mice exposed to whole body irradiation."( Protective role of alpha-phenyl-N-t-butylnitrone against ionizing radiation in U937 cells and mice.
Lee, JH; Park, JW, 2003
)
0.32
" Further, administration of DMSO could be delayed by up to 4 h after MK-801 dosing and still achieve between 80 and 86% reduction in neuronal loss."( Antioxidants attenuate MK-801-induced cortical neurotoxicity in the rat.
Ray, DE; Willis, CL, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Retinoid isomerohydrolase Bos taurus (cattle)IC50 (µMol)100.000010.000010.000010.0000AID1620538
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
visual perceptionRetinoid isomerohydrolase Bos taurus (cattle)
retinol metabolic processRetinoid isomerohydrolase Bos taurus (cattle)
zeaxanthin biosynthetic processRetinoid isomerohydrolase Bos taurus (cattle)
retinoid metabolic processRetinoid isomerohydrolaseGallus gallus (chicken)
visual perceptionRetinoid isomerohydrolaseGallus gallus (chicken)
retinol metabolic processRetinoid isomerohydrolaseGallus gallus (chicken)
zeaxanthin biosynthetic processRetinoid isomerohydrolaseGallus gallus (chicken)
retinal metabolic processRetinoid isomerohydrolaseGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
phosphatidylserine bindingRetinoid isomerohydrolase Bos taurus (cattle)
phosphatidylcholine bindingRetinoid isomerohydrolase Bos taurus (cattle)
identical protein bindingRetinoid isomerohydrolase Bos taurus (cattle)
metal ion bindingRetinoid isomerohydrolase Bos taurus (cattle)
all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activityRetinoid isomerohydrolase Bos taurus (cattle)
all-trans-retinyl-ester hydrolase, 11-cis retinol forming activityRetinoid isomerohydrolase Bos taurus (cattle)
cardiolipin bindingRetinoid isomerohydrolase Bos taurus (cattle)
phosphatidylserine bindingRetinoid isomerohydrolaseGallus gallus (chicken)
isomerase activityRetinoid isomerohydrolaseGallus gallus (chicken)
phosphatidylcholine bindingRetinoid isomerohydrolaseGallus gallus (chicken)
metal ion bindingRetinoid isomerohydrolaseGallus gallus (chicken)
all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activityRetinoid isomerohydrolaseGallus gallus (chicken)
all-trans-retinyl-ester hydrolase, 11-cis retinol forming activityRetinoid isomerohydrolaseGallus gallus (chicken)
cardiolipin bindingRetinoid isomerohydrolaseGallus gallus (chicken)
beta-carotene 15,15'-dioxygenase activityRetinoid isomerohydrolaseGallus gallus (chicken)
retinol isomerase activityRetinoid isomerohydrolaseGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneRetinoid isomerohydrolase Bos taurus (cattle)
plasma membraneRetinoid isomerohydrolase Bos taurus (cattle)
membraneRetinoid isomerohydrolase Bos taurus (cattle)
endoplasmic reticulum membraneRetinoid isomerohydrolaseGallus gallus (chicken)
plasma membraneRetinoid isomerohydrolaseGallus gallus (chicken)
membraneRetinoid isomerohydrolaseGallus gallus (chicken)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (115)

Assay IDTitleYearJournalArticle
AID123234The compound was tested for acute toxicity and activity is expressed as deaths/5 mice after iv (200 mg/kg) administration. 1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
AID729357Toxicity against Chlamydomonas reinhardtii D66 assessed as loss of respiratory activity after 1 hr2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID296902Inhibition of doxorubicin-induced inactivation of mitochondrial NADH:ubiquinone oxidoreductase iron sulfur cluster N2 at 10 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID247569In vitro inhibitory concentration against hydroxyl radical (-OH)2005Bioorganic & medicinal chemistry letters, Jun-15, Volume: 15, Issue:12
Nitrone derivatives of trolox as neuroprotective agents.
AID296907Cytoprotection against doxorubicin-induced toxicity in rotifer assessed as viability at 10 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID85747The concentration producing 50% toxicity in HT-22 hippocampal cell line; No data2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New quinolinic derivatives as centrally active antioxidants.
AID551409Antioxidant activity assessed as hydroxyl radical scavenging activity at 50 uM after 2 hrs by benzoic acid method2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID1310989Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID551411Neuroprotective activity in NMRI mouse assessed as protection against t-BHP-induced lethality at 150 mg/kg, ip after 30 mins relative to control2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID729350Toxicity against Sprague-Dawley rat liver assessed as respiratory control ratio incubated for 1 hr followed by compound washout measured after 10 mins2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID264483Inhibition of peroxynitrite-induced death of mixed cortical cells of E15 Sprague-Dawley rat embryo at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID491822Solubility in water2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID1310992Antioxidant activity assessed as inhibition of allopurinol-xanthine oxidase system-mediated superoxide formation measured over 7 mins by lucigenin-based chemiluminescence analysis2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID307148Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Alpha-phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion.
AID729356Cytotoxicity against mouse 3T3 cells assessed as LDH release per mg of protein at LD10 concentration after 1 hr by spectrophotometric analysis2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID1311005Protection against NADPH-induced superoxide-mediated tissue damage in Sprague-Dawley rat endothelium-intact aortic rings assessed as inhibition of protein carbonyl formation at 200 uM pre-incubated for 30 mins in presence of DTC prior to NADPH addition me2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID390708Neuroprotective activity against human SH-SY5Y cells assessed as inhibition of H2O2-induced cellular damage at 10 uM dosed 1 hr prior to H2O2 challenge after 24 hrs relative to control2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
AID1311001Potentiation of SNP-induced vasorelaxant activity in Sprague-Dawley rat endothelium-intact aortic rings assessed as reduction in L-phenylephrine hydrochloride-induced contraction at 200 uM relative to SNP2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID683737Antioxidant activity against AAPH-induced lipid peroxidation assessed as induction time of inhibition at 0.1 mM2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID546904Protection against light-induced photoreceptor degradation in albino rat retina exposed to 12 hrs dark and 12 hrs light assessed as reduction in ONL thickness on inferior side at 9 mM, intravitreally after 24 hrs2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Cholesterol-based α-phenyl-N-tert-butyl nitrone derivatives as antioxidants against light-induced retinal degeneration.
AID85744The minimum tolerated concentration by MTT reduction assay in HT-22 hippocampal cell line.2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New quinolinic derivatives as centrally active antioxidants.
AID546909Solubility of the compound at 1 mM in PBS2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Cholesterol-based α-phenyl-N-tert-butyl nitrone derivatives as antioxidants against light-induced retinal degeneration.
AID135279Inhibition of t-BHP (tert-butyl-hydro-peroxide) induced toxicity in mice following 150 mg/Kg i.p.2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones.
AID1310999Cytotoxicity against BAECs assessed as decrease in total intracellular LDH content at 15 mM measured after 3 hrs by LDH assay relative to vehicle control2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID1310990Antioxidant activity assessed as DPPH scavenging activity measured after 3 mins by spectrophotometric method2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID491821Lipophilicity, log K in methanol-water mixture by HPLC2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID1311000Potentiation of SNP-induced vasorelaxant activity in Sprague-Dawley rat endothelium-intact aortic rings assessed as SNP EC50 for reduction in L-phenylephrine hydrochloride-induced contraction by (Rvb = 7.98 +/- 0.02 No_unit)2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID349360Antioxidant activity assessed as inhibition of ROS-induced linoleic acid peroxidation at 2 mM after 15 mins at 100 degC by modified TBARS assay relative to control2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
AID264482Inhibition of hydrogen peroxide-induced death of mixed cortical cells of E15 Sprague-Dawley rat embryo at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID248625In vitro inhibitory concentration against peroxynitrite (ONOO-): using pyrogallol red bleaching assay; (na: not active)2005Bioorganic & medicinal chemistry letters, Jun-15, Volume: 15, Issue:12
Nitrone derivatives of trolox as neuroprotective agents.
AID1310991Antioxidant activity assessed as AAPH free radical scavenging activity measured as trolox equivalent by TRAP assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID546906Protection against light-induced photoreceptor degradation in albino rat retina exposed to 12 hrs dark and 12 hrs light assessed as reduction in ONL thickness at 1 mM, intravitreally after 24 hrs2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Cholesterol-based α-phenyl-N-tert-butyl nitrone derivatives as antioxidants against light-induced retinal degeneration.
AID491824Induction of Electron transport protein complex 1 in Sprague-Dawley rat cortical mitochondria assessed as reduction of ferric cyanide at 10 uM after 30 mins in presence of dopamine2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID296901Inhibition of peroxynitrite-induced inactivation of mitochondrial NADH:ubiquinone oxidoreductase iron sulfur cluster N2 at 10 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID683744Induction of NO release in phosphate buffer at pH 7.4 assessed as nitrite level at 0.1 mM by nitrate reductase/NADPH based Griess assay in presence of L-cysteine2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID85745The concentration producing 50% protection against L-HCA-mediated neurotoxicity in HT-22 hippocampal cell line.2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New quinolinic derivatives as centrally active antioxidants.
AID18866Compound was evaluated for half decay time from nitrones with hydroxyl radical1998Bioorganic & medicinal chemistry letters, Feb-17, Volume: 8, Issue:4
Synthesis of alpha-aryl N-adamant-1-yl nitrones and using them for spin trapping of hydroxyl radicals.
AID683741Antioxidant activity assessed as superoxide anion radical scavenging activity at 0.1 mM after 10 mins by tetrazolium dye assay2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID1311007Protection against NADPH-induced superoxide-mediated tissue damage in Sprague-Dawley rat endothelium-intact aortic rings assessed as decomposition of methyl radical adduct preincubated for 30 mins at 200 uM in presence of DTC prior to NADPH addition after2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID264486Viability of rotifers against doxorubicin toxicity at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID729353Drug uptake in Sprague-Dawley rat liver mitochondria incubated for 1 hr followed by compound washout measured after 10 mins2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID1310996Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by luminescence-based ATP assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID52373Maintenance of cell viability by the compound was tested in vitro against cerebellar granule cell cultures from 8-day-old-rats1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
AID1311002Vasoprotective activity against oxidative stress-induced impairment of ACh-stimulated vasorelaxation in Sprague-Dawley rat endothelium-intact aortic rings assessed as reduction in L-phenylephrine hydrochloride-induced contraction preincubated for 10 to 202016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID390713Antioxidant activity assessed as peroxyl free radical scavenging activity by ORAC-fluorescence assay relative to alpha-phenyl-N-tert-butylnitrone2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
AID729355Cytotoxicity against mouse 3T3 cells assessed as cell viability after 3 hrs by spectrophotometric analysis2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID390715Antioxidant activity assessed as reduction of DPPH radical scavenging activity at 10 mM2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
AID307145Protective effect against ischemia/reperfusion-induced microvascular damages in golden hamster assessed as number of leakage site per cm^2 at 3 mg/kg, po after 15 mins by cheek pouch assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Alpha-phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion.
AID349361Neuroprotective effect against H202-induced Sprague-Dawley rat cortical neuron injury assessed as cell viability up to 1 mM treated 30 mins before H202 challenge measured after 24 hrs by MTT assay2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
AID203865In vitro antioxidant activity was measured as IC50, Inhibitory concentration against Liposomal peroxidation.1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
AID729351Toxicity against Sprague-Dawley rat liver assessed as mitochondrial membrane potential incubated for 1 hr followed by compound washout measured after 10 mins2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID296906Cytoprotection against hydrogen peroxide-induced toxicity in rotifer assessed as viability at 10 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID683736Antioxidant activity assessed as inhibition of AAPH-induced lipid peroxidation at 0.1 mM by UV spectrophotometric analysis2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID1310995Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by FMCA assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID491807Induction of Electron transport protein complex 1 in Sprague-Dawley rat cortical mitochondria assessed as reduction of ferric cyanide at 10 uM after 30 mins2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID491817Inhibition of hydrogen peroxide-induced cell death in Sprague-Dawley rat primary mixed cortical cells at 10 uM after 24 hrs by trypan blue absorbance assay2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID683743Induction of NO release in phosphate buffer at pH 7.4 at 0.1 mM by Griess assay in presence of L-cysteine2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID491815Inhibition of doxorubicin-induced cell death in Sprague-Dawley rat primary mixed cortical cells at 10 uM after 24 hrs by trypan blue absorbance assay2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID264481Radical reducing potency by ABTS cation radical reduction assay per 30 mins at 1 umol/mL2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID21643Compound was tested for rat brain permeability at 200 mg/kg i.p. after 30 min1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
AID248216In vitro inhibitory concentration against Total peroxyl radical-trapping antioxidant parameter(TRAP)2005Bioorganic & medicinal chemistry letters, Jun-15, Volume: 15, Issue:12
Nitrone derivatives of trolox as neuroprotective agents.
AID390711Cytotoxicity against mouse J774 cells after 48 hrs by MTT assay2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
AID683875Neuroprotective activity in Sprague-Dawley rat primary cortical neurons assessed as reversal of oxygen-glucose deprivation-induced neuronal damage treated 4 hrs after OGD challenge measured after 24 hrs MTT assay2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID1311003Vasoprotective activity against oxidative stress-induced impairment of ACh-stimulated vasorelaxation in Sprague-Dawley rat endothelium-intact aortic rings assessed as reduction in L-phenylephrine hydrochloride-induced contraction preincubated for 10 to 202016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID264484Inhibition of doxorubicin-induced death of mixed cortical cells of E15 Sprague-Dawley rat embryo at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID296900Inhibition of hydrogen peroxide-induced inactivation of mitochondrial NADH:ubiquinone oxidoreductase iron sulfur cluster N2 at 10 uM2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID21644Compound was tested for rat brain permeability at 200 mg/kg i.p. after 60 min1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
AID683876Neuroprotective activity in Sprague-Dawley rat primary cortical neurons assessed as reversal of oxygen-glucose deprivation-induced neuronal damage at 250 uM by treated 4 hrs after OGD challenge measured after 24 hrs by LDH release assay relative to contro2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID491813Protection against doxorubicin-induced toxicity in Rotifers assessed as viability at 10 uM after 24 hrs2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID155507In vitro inhibition of oxidation of soybean phosphatidylcholine liposomes using lipid peroxidation assay.1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Design, synthesis, and in vitro evaluation of cyclic nitrones as free radical traps for the treatment of stroke.
AID546905Protection against light-induced photoreceptor degradation in albino rat retina exposed to 12 hrs dark and 12 hrs light assessed as reduction in ONL thickness on superior side at 9 mM, intravitreally after 24 hrs2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Cholesterol-based α-phenyl-N-tert-butyl nitrone derivatives as antioxidants against light-induced retinal degeneration.
AID729354Drug uptake in Sprague-Dawley rat liver cytosol incubated for 1 hr followed by compound washout measured after 10 mins2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID264480Hydroxyl radical scavenging activity by ABTS competition assay per 30 mins at 1 umol/mL2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID247539In vitro inhibitory concentration against NO (nitrous oxide)2005Bioorganic & medicinal chemistry letters, Jun-15, Volume: 15, Issue:12
Nitrone derivatives of trolox as neuroprotective agents.
AID52243In vitro antioxidant activity was measured as IC50, inhibition concentration against neuronal peroxidation.1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
AID683740Antioxidant activity assessed as Fe3+/ascorbic acid-induced hydroxyl radical scavenging activity at 0.1 mM after 30 mins2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID695435Antioxidant activity against peroxyl radical production assessed as trolox equivalent by ORAC assay2012European journal of medicinal chemistry, Dec, Volume: 58Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress.
AID546908Half life in albino rat retina2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
Cholesterol-based α-phenyl-N-tert-butyl nitrone derivatives as antioxidants against light-induced retinal degeneration.
AID232027Safety ratio of MTC to that of PC50; Not relevant2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New quinolinic derivatives as centrally active antioxidants.
AID1311009Induction of nitric oxide release in water using Fe2+-MGD2 as nitric oxide trap at pH 6.56 measured 70 mins post UV-photolysis in dark condition by EPR spectroscopy2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID683874Neuroprotective activity in Sprague-Dawley rat primary cortical neurons assessed as reversal of oxygen-glucose deprivation-induced neuronal damage at 5 mM by treated 4 hrs after OGD challenge measured after 24 hrs MTT assay relative to control2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID551406Antioxidant activity of the compound assessed as DPPH radical scavenging activity at 0.5 mM after 2 hrs2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID1310998Cytotoxicity against BAEC assessed as reduction in cell viability measured after 24 hrs by MTT assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID1311004Cytotoxicity against BAECs assessed as reduction in cell viability measured after 24 hrs by neutral red assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID307144Protective effect against ischemia/reperfusion-induced microvascular damages in golden hamster assessed as number of leakage site per cm^2 at 3 mg/kg, po after 10 mins by cheek pouch assay2007Bioorganic & medicinal chemistry, May-15, Volume: 15, Issue:10
Alpha-phenyl-N-tert-butyl nitrone (PBN) derivatives: synthesis and protective action against microvascular damages induced by ischemia/reperfusion.
AID296905Cytoprotection in rat mixed cortical cells cultures assessed as inhibition of doxorubicin-induced cell death at 10 uM after 24 hrs2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID132164In vivo induction of hypothermia in mice following 150 mg/Kg i.p.2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones.
AID696005Permeability of the compound after 4 hrs by PAMPA assay2012European journal of medicinal chemistry, Dec, Volume: 58Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress.
AID458714Chemical stability of hydroxyl radical adduct form assessed as half life of decay in phosphate buffer at pH 7.4 by spectrophotometer2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
New heteroaryl nitrones with spin trap properties: Identification of a 4-furoxanyl derivative with excellent properties to be used in biological systems.
AID390714Antioxidant activity assessed as reduction of DPPH radical scavenging activity at 0.1 mM2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
AID264479Lipophilicity, log k'w of the compound2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID349359Antioxidant activity assessed as inhibition of ROS-induced linoleic acid peroxidation at 1 mM after 15 mins at 100 degC by modified TBARS assay relative to control2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
AID551410Neuroprotective activity against rotenone/oligomycin-A-induced death in human SH-SY5Y cells assessed as increase of cell viability at 1 uM after 2 hrs by MTT assay2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID458715Chemical stability of superoxide radical adduct form assessed as half life of decay in phosphate buffer at pH 7.4 by spectrophotometer2010Bioorganic & medicinal chemistry, Jan-15, Volume: 18, Issue:2
New heteroaryl nitrones with spin trap properties: Identification of a 4-furoxanyl derivative with excellent properties to be used in biological systems.
AID15878Calculated partition coefficient (clogP)2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Synthesis, structure, and neuroprotective properties of novel imidazolyl nitrones.
AID139507Body temperature of NMRI mice after 30 minutes of intraperitoneal administration of 150 mg/kg compound.2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New quinolinic derivatives as centrally active antioxidants.
AID123236The compound was tested for acute toxicity and activity is expressed as deaths/5 mice after iv (400 mg/kg) administration. 1996Journal of medicinal chemistry, Dec-06, Volume: 39, Issue:25
Cyclic nitrone free radical traps: isolation, identification, and synthesis of 3,3-dimethyl-3,4-dihydroisoquinolin-4-ol N-oxide, a metabolite with reduced side effects.
AID683879Neuroprotective activity in Sprague-Dawley rat primary cortical neurons assessed as reversal of oxygen-glucose deprivation-induced neuronal damage at 100 uM by treated 4 hrs after OGD challenge measured after 24 hrs by LDH release assay relative to contro2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
AID349365Inhibition of ADP-induced New Zealand rabbit platelet aggregation at 2 mM treated for 1 min prior to ADP challenge by turbidimetric method relative to control2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
AID491814Protection against hydrogen peroxide-induced toxicity in Rotifers assessed as viability at 10 uM after 24 hrs2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID264485Viability of rotifers against hydrogen peroxide toxicity at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID551408Antioxidant activity assessed as trolox equivalents of peroxyl radical scavenging activity by ORAC assay2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID491816Inhibition of peroxynitrite-induced cell death in Sprague-Dawley rat primary mixed cortical cells at 10 uM after 24 hrs by trypan blue absorbance assay2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID390707Neuroprotective activity against human SH-SY5Y cells assessed as inhibition of H2O2-induced cellular damage at 10 uM after 24 hrs relative to control2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
Heteroarylnitrones as drugs for neurodegenerative diseases: synthesis, neuroprotective properties, and free radical scavenger properties.
AID296903Cytoprotection in rat mixed cortical cells cultures assessed as inhibition of hydrogen peroxide-induced cell death at 10 uM after 24 hrs2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID551414Neuroprotective activity against rotenone/oligomycin-A-induced death in human SH-SY5Y cells assessed as protective effect at 1 uM after 2 hrs by MTT assay2011Bioorganic & medicinal chemistry, Jan-15, Volume: 19, Issue:2
Synthesis, structure, theoretical and experimental in vitro antioxidant/pharmacological properties of α-aryl, N-alkyl nitrones, as potential agents for the treatment of cerebral ischemia.
AID247576In vitro inhibitory concentration against lipid peroxidation (LPO)2005Bioorganic & medicinal chemistry letters, Jun-15, Volume: 15, Issue:12
Nitrone derivatives of trolox as neuroprotective agents.
AID729352Toxicity against Sprague-Dawley rat liver assessed as ATP content incubated for 1 hr followed by compound washout measured after 10 mins2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID140765The compound was tested for % survival of NMRI mice after 5 hours of intraperitoneal administration of 150 mg/kg of dose; 30/602000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
New quinolinic derivatives as centrally active antioxidants.
AID729359Toxicity against Chlamydomonas reinhardtii D66 assessed as loss of photosynthetic activity after 1 hr2013Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6
Synthesis and biological characterization of new aminophosphonates for mitochondrial pH determination by (31)P NMR spectroscopy.
AID491823Induction of Electron transport protein complex 1 in Sprague-Dawley rat cortical mitochondria assessed as reduction of ferric cyanide at 10 uM after 30 mins in presence of EPBNAH2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Amphiphilic amide nitrones: a new class of protective agents acting as modifiers of mitochondrial metabolism.
AID296904Cytoprotection in rat mixed cortical cells cultures assessed as inhibition of peroxynitrite-induced cell death at 10 uM after 24 hrs2007Journal of medicinal chemistry, Aug-23, Volume: 50, Issue:17
Fine-tuning the amphiphilicity: a crucial parameter in the design of potent alpha-phenyl-N-tert-butylnitrone analogues.
AID1310997Cytotoxicity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay2016European journal of medicinal chemistry, Aug-25, Volume: 119On the vasoprotective mechanisms underlying novel β-phosphorylated nitrones: Focus on free radical characterization, scavenging and NO-donation in a biological model of oxidative stress.
AID349371Neuroprotective effect against middle cerebral artery occlusion-induced focal cerebral ischemia in Sprague-Dawley rat assessed as reduction in infarct area at 65 mg/kg, ip administered 1 hr after MCA occlusion measured after 24 hrs of reperfusion by TTC s2008Bioorganic & medicinal chemistry, Oct-01, Volume: 16, Issue:19
Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke.
AID683742Inhibition of soybean lipoxygenase assessed as conversion of sodium linoleate to 13-hydroperoxylinoleic acid at 0.1 mM by competitive inhibition assay2012Journal of medicinal chemistry, Jan-12, Volume: 55, Issue:1
Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (603)

TimeframeStudies, This Drug (%)All Drugs %
pre-199043 (7.13)18.7374
1990's238 (39.47)18.2507
2000's241 (39.97)29.6817
2010's76 (12.60)24.3611
2020's5 (0.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.48%)5.53%
Reviews11 (1.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other610 (97.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]